Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaprisol in euvolemic or hypervolemic hyponatremia
NCT00379847Phase 3Completed
- Sponsor
- Cumberland Pharmaceuticals
- Start
- Feb 2004
- Primary completion
- Jun 2005
- Countries
- 3
01
Overview
A Phase 3 trial of conivaptan in hyponatremia, sponsored by Cumberland Pharmaceuticals. Started Feb 2004; status: completed.
02
Drugs
conivaptan
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT00379847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00379847.